Innovaderm Research Inc.
Quick facts
Marketed products
- Eucerin · Other
Phase 3 pipeline
- Adalimumab every other week · Immunology
Adalimumab is a monoclonal antibody that binds to and neutralizes tumor necrosis factor-alpha (TNF-α), reducing inflammatory signaling. - Adalimumab Every Week · Immunology
Adalimumab is a TNF-alpha inhibitor monoclonal antibody that blocks tumor necrosis factor-alpha to reduce inflammation and immune-mediated disease activity. - Placebo / Xeomin · Neurology / Aesthetics
Xeomin is a botulinum toxin type A that blocks acetylcholine release at the neuromuscular junction, causing temporary muscle paralysis.
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors: